Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary care-based analysis
<p>Abstract</p> <p>Background</p> <p>Insulin glargine (glargine) and premixed insulins (premix) are alternative insulin treatments. This analysis evaluated glycaemic control in 528 patients with type 1 (n = 183) or type 2 (n = 345) diabetes, after switching from premix...
Main Authors: | Tetlow Anthony P, Peters John R, Gordon Jason, Sharplin Peter, Longman Andrea J, McEwan Philip |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-02-01
|
Series: | Cardiovascular Diabetology |
Online Access: | http://www.cardiab.com/content/8/1/9 |
Similar Items
-
Improved glycaemic control by switching from insulin NPH to insulin glargine: a retrospective observational study
by: Tetlow Anthony P, et al.
Published: (2009-01-01) -
Initiation of insulin glargine plus oral antidiabetic drugs in patients with type 2 diabetes uncontrolled on premixed insulin
by: Ghaida Kaddaha
Published: (2017-01-01) -
Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled Type 2 diabetes in the United Kingdom
by: Tetlow Anthony P, et al.
Published: (2008-08-01) -
Real world outcomes of adding rapid-acting insulin versus switching to analog premix insulin among US patients with type 2 diabetes treated with insulin glargine
by: Miao R, et al.
Published: (2013-09-01) -
Immunogenicity and Efficacy of Insulin Glargine Biosimilar Ezelin versus Originator Insulin Glargine in Patients with Type 2 Diabetes
by: Tarigan TJE, et al.
Published: (2021-01-01)